FDA Investigator: Zhongren Wu

- Zhongren Wu first started conducting FDA inspections in 2015, with the last inspection in 2023. Over that time, Zhongren Wu has conducted 70 inspections at 69 companies across 70 sites.

Get Zhongren Wu's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Bristol Myers Squibb Company, Devens | 2023

Out-of-stock
Zhongren Wu
Biologics Form 483

FDA 483 TWI Pharmaceuticals, Inc. - Zhongli Plant, Taoyuan City | 2020

Out-of-stock
Zhongren Wu
Human Drug Form 483

FDA 483 Blue Circle Organics Pvt. Ltd., Ambernath | 2019

Out-of-stock
Zhongren Wu
Human Drug Form 483

FDA 483 Sunstar Guangzhou Ltd., Guangzhou | 2019

Out-of-stock
Zhongren Wu
Human Drug Form 483

FDA 483 Nalanda Research Laboratories, Navi Mumbai | 2019

Out-of-stock
Zhongren Wu
Human Drug Form 483

FDA 483 Gelnova Laboratories (India) Pvt. Ltd., Navi Mumbai | 2019

Out-of-stock
Zhongren Wu
Human Drug Form 483